🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/09/2023 | 58,77 | 59,53 | 57,94 | 58,86 | -0,37% | 2,71% | 64.300 |
| 22/09/2023 | 59,28 | 59,93 | 58,69 | 59,08 | -0,40% | 2,09% | 94.600 |
| 21/09/2023 | 60,44 | 61,00 | 59,10 | 59,32 | -2,85% | 3,14% | 112.100 |
| 20/09/2023 | 63,67 | 63,67 | 60,99 | 61,06 | -3,54% | 4,21% | 66.700 |
| 19/09/2023 | 62,88 | 63,75 | 62,74 | 63,30 | +1,18% | 1,61% | 84.700 |
| 18/09/2023 | 62,22 | 62,64 | 61,23 | 62,56 | +0,94% | 2,27% | 92.300 |
| 15/09/2023 | 62,52 | 62,80 | 61,22 | 61,98 | -0,50% | 2,53% | 342.900 |
| 14/09/2023 | 62,99 | 63,30 | 62,10 | 62,29 | -0,70% | 1,91% | 159.400 |
| 13/09/2023 | 62,58 | 63,12 | 62,01 | 62,73 | +0,03% | 1,77% | 144.900 |
| 12/09/2023 | 63,50 | 63,60 | 62,47 | 62,71 | -1,45% | 1,78% | 77.300 |
| 11/09/2023 | 63,50 | 63,94 | 62,89 | 63,63 | +0,92% | 1,65% | 91.600 |
| 08/09/2023 | 63,58 | 63,65 | 62,74 | 63,05 | -0,74% | 1,43% | 58.900 |
| 07/09/2023 | 64,52 | 64,72 | 63,50 | 63,52 | -1,47% | 1,89% | 83.400 |
| 06/09/2023 | 63,79 | 64,53 | 63,42 | 64,47 | +1,48% | 1,74% | 84.600 |
| 05/09/2023 | 65,97 | 65,97 | 63,53 | 63,53 | -4,52% | 3,70% | 117.400 |
| 01/09/2023 | 66,16 | 67,48 | 65,90 | 66,54 | +1,17% | 2,39% | 110.800 |
| 31/08/2023 | 66,08 | 66,14 | 65,10 | 65,77 | -0,63% | 1,57% | 117.600 |
| 30/08/2023 | 64,36 | 66,67 | 64,06 | 66,19 | +2,83% | 4,06% | 115.400 |
| 29/08/2023 | 64,96 | 65,00 | 64,11 | 64,37 | -0,91% | 1,37% | 94.000 |
| 28/08/2023 | 65,76 | 66,57 | 64,55 | 64,96 | -0,66% | 3,07% | 71.700 |
| 25/08/2023 | 66,22 | 66,54 | 65,10 | 65,39 | -1,04% | 2,17% | 86.300 |
| 24/08/2023 | 67,07 | 67,45 | 65,49 | 66,08 | -1,62% | 2,92% | 84.500 |
| 23/08/2023 | 67,44 | 68,14 | 66,42 | 67,17 | +1,16% | 2,55% | 99.800 |
| 22/08/2023 | 66,27 | 66,96 | 65,38 | 66,40 | +0,27% | 2,38% | 74.900 |
| 21/08/2023 | 66,09 | 66,77 | 65,79 | 66,22 | +0,06% | 1,48% | 69.500 |
| 18/08/2023 | 66,00 | 66,80 | 65,79 | 66,18 | -0,59% | 1,53% | 109.700 |
| 17/08/2023 | 66,77 | 67,90 | 66,10 | 66,57 | -0,39% | 2,70% | 87.300 |
| 16/08/2023 | 67,24 | 67,35 | 66,19 | 66,83 | -1,12% | 1,73% | 64.500 |
| 15/08/2023 | 66,62 | 67,73 | 65,52 | 67,59 | +0,66% | 3,32% | 78.800 |
| 14/08/2023 | 66,78 | 68,15 | 65,90 | 67,15 | -0,10% | 3,37% | 96.400 |